Global Oral Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2025

Published: Nov, 2019 | Pages: 119 | Publisher: XYZResearch
Industry: Medical Devices | Report Format: Electronic (PDF)

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Oral Vaccines in these regions, from 2012 to 2023 (forecast), covering
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    South America (Brazil, Argentina, Columbia)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Oral Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    GlaxoSmithKline Plc.
    PaxVax Corporation
    Pfizer Inc
    Merial, Inc.
    Merck Sharp & Dohme Corp
    VALNEVA Canada Inc.
    QUiMICA SUIZA S.A
    Immunitor, Inc
    Aventis (Sanofi S.A.)
    Serum Institute of India Pvt. Ltd
    Swiss Serum and Vaccine Institute Berne
    Bull Bio - NCIPD Ltd.
    Vaxart, Inc.
    Shantha Biotechnics
    Crucell (Janssen Global Services, LLC)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Live Attenuated Vaccines
    Killed/Inactivated Vaccines
    Recombinant Vaccines
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oral Vaccines for each application, including
    Polio
    Rabies
    Rotavirus
    Cholera
    HIV
    Respiratory Infections
    Influenza
    Tuberculosis
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Oral Vaccines Market by Manufacturers, Regions, Type and Application, Forecast to 2025
1 Report Overview
    1.1 Definition and Specification
    1.2 Report Overview
        1.2.1 Manufacturers Overview
        1.2.2 Regions Overview
        1.2.3 Type Overview
        1.2.4 Application Overview
    1.3 Industrial Chain
        1.3.1 Oral Vaccines Overall Industrial Chain
        1.3.2 Upstream
        1.3.3 Downstream
    1.4 Industry Situation
        1.4.1 Industrial Policy
        1.4.2 Product Preference
        1.4.3 Economic/Political Environment
    1.5 SWOT Analysis
2 Product Type Market
    2.1 World Product Type Market Performance and Trend
        2.1.1 World Market Performance
        2.1.2 Different Type of Market Performance
    2.2 North America Product Type Market Performance and Trend
        2.2.1 North America Market Performance
        2.2.2 Different Type of Market Performance
    2.3 Europe Product Type Market Performance and Trend
        2.3.1 Europe Market Performance
        2.3.2 Different Type of Market Performance
    2.4 Asia-Pacific Product Type Market Performance and Trend
        2.4.1 Asia-Pacific Market Performance
        2.4.2 Different Type of Market Performance
    2.5 South America Product Type Market Performance and Trend
        2.5.1 South America Market Performance
        2.5.2 Different Type of Market Performance
    2.6 Middle East and Africa  Product Type Market Performance and Trend
        2.6.1 Middle East and Africa  Market Performance
        2.6.2 Different Type of Market Performance
3 Product Application Market
    3.1 World Product Application Market Performance and Trend
        3.1.1 World Market Performance
        3.1.2 Different Applications of Market Trend
    3.2 North America Product Application Market Performance and Trend
        3.2.1 North America Market Performance
        3.2.2 Different Applications of Market Trend
    3.3 Europe Product Application Market Performance and Trend
        3.3.1 Europe Market Performance
        3.3.2 Different Applications of Market Trend
    3.4 Asia-Pacific Product Application Market Performance and Trend
        3.4.1 Asia-Pacific Market Performance
        3.4.2 Different Applications of Market Trend
    3.5 South America Product Application Market Performance and Trend
        3.5.1 South America Market Performance
        3.5.2 Different Applications of Market Trend
    3.6 Middle East and Africa  Product Application Market Performance and Trend
        3.6.1 Middle East and Africa  Market Performance
        3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
    4.1 GlaxoSmithKline Plc.
        4.1.1 GlaxoSmithKline Plc. Profiles
        4.1.2 GlaxoSmithKline Plc. Product Information
        4.1.3 GlaxoSmithKline Plc. Oral Vaccines Business Performance
        4.1.4 GlaxoSmithKline Plc. Oral Vaccines Business Development and Market Status
    4.2 PaxVax Corporation
        4.2.1 PaxVax Corporation Profiles
        4.2.2 PaxVax Corporation Product Information
        4.2.3 PaxVax Corporation Oral Vaccines Business Performance
        4.2.4 PaxVax Corporation Oral Vaccines Business Development and Market Status
    4.3 Pfizer Inc
        4.3.1 Pfizer Inc Profiles
        4.3.2 Pfizer Inc Product Information
        4.3.3 Pfizer Inc Oral Vaccines Business Performance
        4.3.4 Pfizer Inc Oral Vaccines Business Development and Market Status
    4.4 Merial, Inc.
        4.4.1 Merial, Inc. Profiles
        4.4.2 Merial, Inc. Product Information
        4.4.3 Merial, Inc. Oral Vaccines Business Performance
        4.4.4 Merial, Inc. Oral Vaccines Business Development and Market Status
    4.5 Merck Sharp & Dohme Corp
        4.5.1 Merck Sharp & Dohme Corp Profiles
        4.5.2 Merck Sharp & Dohme Corp Product Information
        4.5.3 Merck Sharp & Dohme Corp Oral Vaccines Business Performance
        4.5.4 Merck Sharp & Dohme Corp Oral Vaccines Business Development and Market Status
    4.6 VALNEVA Canada Inc.
        4.6.1 VALNEVA Canada Inc. Profiles
        4.6.2 VALNEVA Canada Inc. Product Information
        4.6.3 VALNEVA Canada Inc. Oral Vaccines Business Performance
        4.6.4 VALNEVA Canada Inc. Oral Vaccines Business Development and Market Status
    4.7 QUiMICA SUIZA S.A
        4.7.1 QUiMICA SUIZA S.A Profiles
        4.7.2 QUiMICA SUIZA S.A Product Information
        4.7.3 QUiMICA SUIZA S.A Oral Vaccines Business Performance
        4.7.4 QUiMICA SUIZA S.A Oral Vaccines Business Development and Market Status
    4.8 Immunitor, Inc
        4.8.1 Immunitor, Inc Profiles
        4.8.2 Immunitor, Inc Product Information
        4.8.3 Immunitor, Inc Oral Vaccines Business Performance
        4.8.4 Immunitor, Inc Oral Vaccines Business Development and Market Status
    4.9 Aventis (Sanofi S.A.)
        4.9.1 Aventis (Sanofi S.A.) Profiles
        4.9.2 Aventis (Sanofi S.A.) Product Information
        4.9.3 Aventis (Sanofi S.A.) Oral Vaccines Business Performance
        4.9.4 Aventis (Sanofi S.A.) Oral Vaccines Business Development and Market Status
    4.10 Serum Institute of India Pvt. Ltd
        4.10.1 Serum Institute of India Pvt. Ltd Profiles
        4.10.2 Serum Institute of India Pvt. Ltd Product Information
        4.10.3 Serum Institute of India Pvt. Ltd Oral Vaccines Business Performance
        4.10.4 Serum Institute of India Pvt. Ltd Oral Vaccines Business Development and Market Status
    4.11 Swiss Serum and Vaccine Institute Berne
    4.12 Bull Bio - NCIPD Ltd.
    4.13 Vaxart, Inc.
    4.14 Shantha Biotechnics
    4.15 Crucell (Janssen Global Services, LLC)
5 Market Performance for Manufacturers
    5.1 Global Oral Vaccines Sales (K Units) and Market Share by Manufacturers 2014-2019
    5.2 Global Oral Vaccines Revenue (M USD) and Market Share by Manufacturers 2014-2019
    5.3 Global Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
    5.4 Global Oral Vaccines Gross Margin of Manufacturers 2014-2019
    5.5 Market Concentration
6 Regions Market Performance for Manufacturers
    6.1 North America Market Performance for Manufacturers
        6.1.1 North America Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
        6.1.2 North America Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
        6.1.3 North America Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
        6.1.4 North America Oral Vaccines Gross Margin of Manufacturers 2014-2019
        6.1.5 Market Concentration
    6.2 Europe Market Performance for Manufacturers
        6.2.1 Europe Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
        6.2.2 Europe Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
        6.2.3 Europe Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
        6.2.4 Europe Oral Vaccines Gross Margin of Manufacturers 2014-2019
        6.2.5 Market Concentration
    6.3 Asia-Pacific Market Performance for Manufacturers
        6.3.1 Asia-Pacific Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
        6.3.2 Asia-Pacific Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
        6.3.3 Asia-Pacific Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
        6.3.4 Asia-Pacific Oral Vaccines Gross Margin of Manufacturers 2014-2019
        6.3.5 Market Concentration
    6.4 South America Market Performance for Manufacturers
        6.4.1 South America Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
        6.4.2 South America Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
        6.4.3 South America Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
        6.4.4 South America Oral Vaccines Gross Margin of Manufacturers 2014-2019
        6.4.5 Market Concentration
    6.5 Middle East and Africa  Market Performance for Manufacturers
        6.5.1 Middle East and Africa  Oral Vaccines Sales (K Units) and Share of Manufacturers 2014-2019
        6.5.2 Middle East and Africa  Oral Vaccines Revenue (M USD) and Share of Manufacturers 2014-2019
        6.5.3 Middle East and Africa  Oral Vaccines Price (USD/Unit) of Manufacturers 2014-2019
        6.5.4 Middle East and Africa  Oral Vaccines Gross Margin of Manufacturers 2014-2019
        6.5.5 Market Concentration
7 World Market Performance Point
    7.1 World Oral Vaccines Sales (K Units) and Share by Regions and Countries 2014-2019
        7.1.1 World Oral Vaccines Sales (K Units) and Share by Regions 2014-2019
        7.1.2 Regional Sales (K Units) and Share by Countries 2014-2019
            7.1.2.1 Asia-Pacific Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
            7.1.2.2 North America Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
            7.1.2.3 Europe Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
            7.1.2.4 South America Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
            7.1.2.5 Middle East and Africa  Oral Vaccines Sales (K Units) and Share by Countries 2014-2019
    7.2 World Revenue (M USD) and Share by Regions and Countries 2014-2019
        7.2.1 World Revenue (M USD) and Share by Regions 2014-2019
        7.2.2 Regional Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.1 Asia-Pacific Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.2 North America Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.3 Europe Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.4 South America Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
            7.2.2.5 Middle East and Africa  Oral Vaccines Revenue (M USD) and Share by Countries 2014-2019
    7.3 World Price (USD/Unit) by Regions and Countries 2014-2019
        7.3.1 World Price (USD/Unit) by Regions 2014-2019
        7.3.2 Regional Price (USD/Unit) by Countries 2014-2019
            7.3.2.1 Asia-Pacific Oral Vaccines Price (USD/Unit) by Countries 2014-2019
            7.3.2.2 North America Oral Vaccines Price (USD/Unit) by Countries 2014-2019
            7.3.2.3 Europe Oral Vaccines Price (USD/Unit) by Countries 2014-2019
            7.3.2.4 South America Oral Vaccines Price (USD/Unit) by Countries 2014-2019
            7.3.2.5 Middle East and Africa  Oral Vaccines Price (USD/Unit) by Countries 2014-2019
    7.4 World Gross Margin by Regions and Countries 2014-2019
        7.4.1 World Gross Margin by Regions 2014-2019
        7.4.2 Regional Gross Margin and Share by Countries 2014-2019
            7.4.2.1 Asia-Pacific Oral Vaccines Gross Margin and Share by Countries 2014-2019
            7.4.2.2 North America Oral Vaccines Gross Margin and Share by Countries 2014-2019
            7.4.2.3 Europe Oral Vaccines Gross Margin and Share by Countries 2014-2019
            7.4.2.4 South America Oral Vaccines Gross Margin and Share by Countries 2014-2019
            7.4.2.5 Middle East and Africa  Oral Vaccines Gross Margin and Share by Countries 2014-2019
8 Development Trend for Regions and Countries (Sales Point)
   8.1 World Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.3 North America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.4 Europe Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.5 South America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
   8.6 Middle East and Africa  Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
        8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2014-2019
9 Upstream Source, Technology and Cost
    9.1 Upstream Source
    9.2 Technology
    9.3 Cost
10 Channel Analysis
    10.1 Market Channel
    10.2 Distributors
11 Consumer Analysis
    11.1 Polio Industry 
    11.2 Rabies Industry 
    11.3 Rotavirus Industry 
    11.4 Cholera Industry 
    11.5 HIV Industry 
    11.6 Respiratory Infections Industry 
    11.7 Influenza Industry 
    11.8 Tuberculosis Industry 
    11.9 Others Industry 
12 Market Forecast 2020-2025
    12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
        12.1.1 Global Oral Vaccines Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
        12.1.2 Global Oral Vaccines Sales (K Units) and Growth Rate 2020-2025
        12.1.3 Asia-Pacific Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.4 North America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.5 Europe Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.6 South America Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.1.7 Middle East and Africa  Oral Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    12.2 World Oral Vaccines Sales (K Units) and Revenue (M USD) Forecast by Types 2020-2025
        12.2.1 Overall Market Performance
        12.2.2 Live Attenuated Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.2.3 Killed/Inactivated Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.2.4 Recombinant Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
        12.2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    12.3 World Oral Vaccines Market Forecast by Application 2020-2025
        12.3.1 Overall Market Performance
        12.3.2 Polio Sales and and Growth Rate 2020-2025
        12.3.3 Rabies Sales and and Growth Rate 2020-2025
        12.3.4 Rotavirus Sales and and Growth Rate 2020-2025
        12.3.5 Cholera Sales and and Growth Rate 2020-2025
        12.3.6 HIV Sales and and Growth Rate 2020-2025
        12.3.7 Respiratory Infections Sales and and Growth Rate 2020-2025
        12.3.8 Influenza Sales and and Growth Rate 2020-2025
        12.3.9 Tuberculosis Sales and and Growth Rate 2020-2025
        12.3.10 Others Sales and and Growth Rate 2020-2025
    12.4 Price (USD/Unit) and Gross Profit Forecast
        12.4.1 Global Oral Vaccines Price (USD/Unit) Trend 2020-2025
        12.4.2 Global Oral Vaccines Gross Profit Trend 2020-2025
13 Conclusion

List of Tables and Figures
Figure Product Picture of Oral Vaccines
Table Product Specifications of Oral Vaccines
Table Manufacturers List in the Report
Table Manufacturers Market Share 2014-2019
Table Regions Overview in the Report
Table Product Type and Standard
Table Type Overview
Table Product Application and Standard
Table Application Overview in the Report
Figure Industry Chain Structure of Oral Vaccines
Table Industry News List of Oral Vaccines
Figure New Project SWOT Analysis of Oral Vaccines
Table World 2014-2019 Oral Vaccines Sales (K Units) by Type
Figure World Oral Vaccines Sales Market Share (%) by Type in 2014
Figure World Oral Vaccines Sales Market Share (%) by Type in 2019
Table World 2014-2019 Oral VaccinesRevenue (M USD) by Type
Figure World Oral VaccinesRevenue Market Share (%) by Type in 2014
Figure World Oral VaccinesRevenue Market Share (%) by Type in 2019
Table World Live Attenuated Vaccines Sales (K Units) and Growth Rate
Figure World Live Attenuated Vaccines Sales (K Units) and Growth Rate
Table World Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Figure World Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Table World Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Figure World Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Table World Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Figure World Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Table World Recombinant Vaccines Sales (K Units) and Growth Rate
Figure World Recombinant Vaccines Sales (K Units) and Growth Rate
Table World Recombinant Vaccines Revenue (M USD) and Growth Rate
Figure World Recombinant Vaccines Revenue (M USD) and Growth Rate
Table World Others Sales (K Units) and Growth Rate
Figure World Others Sales (K Units) and Growth Rate
Table World Others Revenue (M USD) and Growth Rate
Figure World Others Revenue (M USD) and Growth Rate
Table North America 2014-2019 Oral Vaccines Sales (K Units) by Type
Figure North America Oral Vaccines Sales Market Share (%) by Type in 2014
Figure North America Oral Vaccines Sales Market Share (%) by Type in 2019
Table North America 2014-2019 Oral VaccinesRevenue (M USD) by Type
Figure North America Oral Vaccines Revenue Market Share (%) by Type in 2014
Figure North America Oral Vaccines Revenue Market Share (%) by Type in 2019
Table North America Live Attenuated Vaccines Sales (K Units) and Growth Rate
Figure North America Live Attenuated Vaccines Sales (K Units) and Growth Rate
Table North America Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Figure North America Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Table North America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Figure North America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Table North America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Figure North America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Table North America Recombinant Vaccines Sales (K Units) and Growth Rate
Figure North America Recombinant Vaccines Sales (K Units) and Growth Rate
Table North America Recombinant Vaccines Revenue (M USD) and Growth Rate
Figure North America Recombinant Vaccines Revenue (M USD) and Growth Rate
Table North America Others Sales (K Units) and Growth Rate
Figure North America Others Sales (K Units) and Growth Rate
Table North America Others Revenue (M USD) and Growth Rate
Figure North America Others Revenue (M USD) and Growth Rate
Table Europe 2014-2019 Oral Vaccines Sales (K Units) by Type
Figure Europe Oral Vaccines Sales Market Share (%) by Type in 2014
Figure Europe Oral Vaccines Sales Market Share (%) by Type in 2019
Table Europe 2014-2019 Oral VaccinesRevenue (M USD) by Type
Figure Europe Oral VaccinesRevenue Market Share (%) by Type in 2014
Figure Europe Oral VaccinesRevenue Market Share (%) by Type in 2019
Table Europe Live Attenuated Vaccines Sales (K Units) and Growth Rate
Figure Europe Live Attenuated Vaccines Sales (K Units) and Growth Rate
Table Europe Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Figure Europe Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Table Europe Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Figure Europe Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Table Europe Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Figure Europe Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Table Europe Recombinant Vaccines Sales (K Units) and Growth Rate
Figure Europe Recombinant Vaccines Sales (K Units) and Growth Rate
Table Europe Recombinant Vaccines Revenue (M USD) and Growth Rate
Figure Europe Recombinant Vaccines Revenue (M USD) and Growth Rate
Table Europe Others Sales (K Units) and Growth Rate
Figure Europe Others Sales (K Units) and Growth Rate
Table Europe Others Revenue (M USD) and Growth Rate
Figure Europe Others Revenue (M USD) and Growth Rate
Table Asia-Pacific 2014-2019 Oral Vaccines Sales (K Units) by Type
Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Type in 2014
Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Type in 2019
Table Asia-Pacific 2014-2019 Oral VaccinesRevenue (M USD) by Type
Figure Asia-Pacific Oral VaccinesRevenue Market Share (%) by Type in 2014
Figure Asia-Pacific Oral VaccinesRevenue Market Share (%) by Type in 2019
Table Asia-Pacific Live Attenuated Vaccines Sales (K Units) and Growth Rate
Figure Asia-Pacific Live Attenuated Vaccines Sales (K Units) and Growth Rate
Table Asia-Pacific Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Figure Asia-Pacific Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Table Asia-Pacific Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Figure Asia-Pacific Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Table Asia-Pacific Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Figure Asia-Pacific Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Table Asia-Pacific Recombinant Vaccines Sales (K Units) and Growth Rate
Figure Asia-Pacific Recombinant Vaccines Sales (K Units) and Growth Rate
Table Asia-Pacific Recombinant Vaccines Revenue (M USD) and Growth Rate
Figure Asia-Pacific Recombinant Vaccines Revenue (M USD) and Growth Rate
Table Asia-Pacific Others Sales (K Units) and Growth Rate
Figure Asia-Pacific Others Sales (K Units) and Growth Rate
Table Asia-Pacific Others Revenue (M USD) and Growth Rate
Figure Asia-Pacific Others Revenue (M USD) and Growth Rate
Table South America 2014-2019 Oral Vaccines Sales (K Units) by Type
Figure South America Oral Vaccines Sales Market Share (%) by Type in 2014
Figure South America Oral Vaccines Sales Market Share (%) by Type in 2019
Table South America 2014-2019 Oral VaccinesRevenue (M USD) by Type
Figure South America Oral VaccinesRevenue Market Share (%) by Type in 2014
Figure South America Oral VaccinesRevenue Market Share (%) by Type in 2019
Table South America Live Attenuated Vaccines Sales (K Units) and Growth Rate
Figure South America Live Attenuated Vaccines Sales (K Units) and Growth Rate
Table South America Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Figure South America Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Table South America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Figure South America Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Table South America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Figure South America Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Table South America Recombinant Vaccines Sales (K Units) and Growth Rate
Figure South America Recombinant Vaccines Sales (K Units) and Growth Rate
Table South America Recombinant Vaccines Revenue (M USD) and Growth Rate
Figure South America Recombinant Vaccines Revenue (M USD) and Growth Rate
Table South America Others Sales (K Units) and Growth Rate
Figure South America Others Sales (K Units) and Growth Rate
Table South America Others Revenue (M USD) and Growth Rate
Figure South America Others Revenue (M USD) and Growth Rate
Table Middle East and Africa  2014-2019 Oral Vaccines Sales (K Units) by Type
Figure Middle East and Africa  Oral Vaccines Sales Market Share (%) by Type in 2014
Figure Middle East and Africa  Oral Vaccines Sales Market Share (%) by Type in 2019
Table Middle East and Africa  2014-2019 Oral VaccinesRevenue (M USD) by Type
Figure Middle East and Africa  Oral VaccinesRevenue Market Share (%) by Type in 2014
Figure Middle East and Africa  Oral VaccinesRevenue Market Share (%) by Type in 2019
Table Middle East and Africa  Live Attenuated Vaccines Sales (K Units) and Growth Rate
Figure Middle East and Africa  Live Attenuated Vaccines Sales (K Units) and Growth Rate
Table Middle East and Africa  Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Live Attenuated Vaccines Revenue (M USD) and Growth Rate
Table Middle East and Africa  Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Figure Middle East and Africa  Killed/Inactivated Vaccines Sales (K Units) and Growth Rate
Table Middle East and Africa  Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Killed/Inactivated Vaccines Revenue (M USD) and Growth Rate
Table Middle East and Africa  Recombinant Vaccines Sales (K Units) and Growth Rate
 Figure Middle East and Africa  Recombinant Vaccines Sales (K Units) and Growth Rate
Table Middle East and Africa  Recombinant Vaccines Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Recombinant Vaccines Revenue (M USD) and Growth Rate
Table Middle East and Africa  Others Sales (K Units) and Growth Rate
Figure Middle East and Africa  Others Sales (K Units) and Growth Rate
Table Middle East and Africa  Others Revenue (M USD) and Growth Rate
Figure Middle East and Africa  Others Revenue (M USD) and Growth Rate
Table World 2014-2019 Oral Vaccines Sales (K Units) by Application
Figure World Oral Vaccines Sales Market Share (%) by Application in 2014
Figure World Oral Vaccines Sales Market Share (%) by Application in 2019
Table World  Polio Sales (K Units) and Growth Rate
Figure World  Polio Sales (K Units) and Growth Rate
Table World  Rabies Sales (K Units) and Growth Rate
Figure World  Rabies Sales (K Units) and Growth Rate
Table World  Rotavirus Sales (K Units) and Growth Rate
Figure World  Rotavirus Sales (K Units) and Growth Rate
Table World  Cholera Sales (K Units) and Growth Rate
Figure World  Cholera Sales (K Units) and Growth Rate
Table North America Oral Vaccines Sales (K Units) by Application 2014-2019
Figure North America Oral Vaccines Sales Market Share (%) by Application in 2014
Figure North America Oral Vaccines Sales Market Share (%) by Application in 2019
Table North America  Polio Sales (K Units) and Growth Rate
Figure North America  Polio Sales (K Units) and Growth Rate
Table North America  Rabies Sales (K Units) and Growth Rate
Figure North America  Rabies Sales (K Units) and Growth Rate
Table North America  Rotavirus Sales (K Units) and Growth Rate
Figure North America  Rotavirus Sales (K Units) and Growth Rate
Table North America  Cholera Sales (K Units) and Growth Rate
Figure North America  Cholera Sales (K Units) and Growth Rate
Table Europe 2014-2019 Oral Vaccines Sales (K Units) by Application
Figure Europe Oral Vaccines Sales Market Share (%) by Application in 2014
Figure Europe Oral Vaccines Sales Market Share (%) by Application in 2019
Table Europe  Polio Sales (K Units) and Growth Rate
Figure Europe  Polio Sales (K Units) and Growth Rate
Table Europe  Rabies Sales (K Units) and Growth Rate
Figure Europe  Rabies Sales (K Units) and Growth Rate
Table Europe  Rotavirus Sales (K Units) and Growth Rate
Figure Europe  Rotavirus Sales (K Units) and Growth Rate
Table Europe  Cholera Sales (K Units) and Growth Rate
Figure Europe  Cholera Sales (K Units) and Growth Rate
Table Asia-Pacific 2014-2019 Oral Vaccines Sales (K Units) by Application
Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Application in 2014
Figure Asia-Pacific Oral Vaccines Sales Market Share (%) by Application in 2019
Table Asia-Pacific  Polio Sales (K Units) and Growth Rate
Figure Asia-Pacific  Polio Sales (K Units) and Growth Rate
Table Asia-Pacific  Rabies Sales (K Units) and Growth Rate
Figure Asia-Pacific  Rabies Sales (K Units) and Growth Rate
Table Asia-Pacific  Rotavirus Sales (K Units) and Growth Rate
Figure Asia-Pacific  Rotavirus Sales (K Units) and Growth Rate
Table Asia-Pacific  Cholera Sales (K Units) and Growth Rate
Figure Asia-Pacific  Cholera Sales (K Units) and Growth Rate
Table South America 2014-2019 Oral Vaccines Sales (K Units) by Application
Figure South America Oral Vaccines Sales Market Share (%) by Application in 2014
Figure South America Oral Vaccines Sales Market Share (%) by Application in 2019
Table South America  Polio Sales (K Units) and Growth Rate
Figure South America  Polio Sales (K Units) and Growth Rate
Table South America  Rabies Sales (K Units) and Growth Rate
Figure South America  Rabies Sales (K Units) and Growth Rate
Table South America  Rotavirus Sales (K Units) and Growth Rate
Figure South America  Rotavirus Sales (K Units) and Growth Rate
Table South America  Cholera Sales (K Units) and Growth Rate
Figure South America  Cholera Sales (K Units) and Growth Rate
Table Middle East and Africa  2014-2019 Oral Vaccines Sales (K Units) by Application
Figure Middle East and Africa  Oral Vaccines Sales Market Share (%) by Application in 2014
Figure Middle East and Africa  Oral Vaccines Sales Market Share (%) by Application in 2019
Table Middle East and Africa   Polio Sales (K Units) and Growth Rate
Figure Middle East and Africa   Polio Sales (K Units) and Growth Rate
Table Middle East and Africa   Rabies Sales (K Units) and Growth Rate
Figure Middle East and Africa   Rabies Sales (K Units) and Growth Rate
Table Middle East and Africa   Rotavirus Sales (K Units) and Growth Rate
Figure Middle East and Africa   Rotavirus Sales (K Units) and Growth Rate
Table Middle East and Africa   Cholera Sales (K Units) and Growth Rate
Figure Middle East and Africa   Cholera Sales (K Units) and Growth Rate
Table GlaxoSmithKline Plc. Profiles
Table GlaxoSmithKline Plc. Product Information
Table GlaxoSmithKline Plc. Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table GlaxoSmithKline Plc. Oral Vaccines Sales Change 2014-2019
Table GlaxoSmithKline Plc. Oral Vaccines Market Status Change 2014-2019
Table PaxVax Corporation Profiles
Table PaxVax Corporation Product Information
Table PaxVax Corporation Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table PaxVax Corporation Oral Vaccines Sales Change 2014-2019
Table PaxVax Corporation Oral Vaccines Market Status Change 2014-2019
Table Pfizer Inc Profiles
Table Pfizer Inc Product Information
Table Pfizer Inc Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Pfizer Inc Oral Vaccines Sales Change 2014-2019
Table Pfizer Inc Oral Vaccines Market Status Change 2014-2019
Table Merial, Inc. Profiles
Table Merial, Inc. Product Information
Table Merial, Inc. Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Merial, Inc. Oral Vaccines Sales Change 2014-2019
Table Merial, Inc. Oral Vaccines Market Status Change 2014-2019
Table Merck Sharp & Dohme Corp Profiles
Table Merck Sharp & Dohme Corp Product Information
Table Merck Sharp & Dohme Corp Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table Merck Sharp & Dohme Corp Oral Vaccines Sales Change 2014-2019
Table Merck Sharp & Dohme Corp Oral Vaccines Market Status Change 2014-2019
Table VALNEVA Canada Inc. Profiles
Table VALNEVA Canada Inc. Product Information
Table VALNEVA Canada Inc. Oral Vaccines Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2019
Table VALNEVA Canada Inc. Oral Vaccines Sales Change 2014-2019
Table VALNEVA Canada Inc. Oral Vaccines Market Status Change 2014-2019
Table QUíMICA SUIZA S.A Profiles